TGF-β signaling is mediated by two specific cellular serine/threonine kinase receptors, namely TGFBR1 and TGFBR2, and it can induce EMT in tumor cells in association with the acquisition of motility and invasive properties [9]. This evidence concerns the gene TGFB1 and neoplasm.